Literature DB >> 18085728

Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR).

Edward M Behrens1, Timothy Beukelman, Lisa Gallo, Julie Spangler, Margalit Rosenkranz, Thaschawee Arkachaisri, Rosanne Ayala, Brandt Groh, Terri H Finkel, Randy Q Cron.   

Abstract

OBJECTIVE: To characterize the initial clinical and laboratory features of patients with systemic onset juvenile rheumatoid arthritis (soJRA) through a Web-based registry.
METHODS: Patients diagnosed with soJRA in the last 15 years at 3 medical centers in Pennsylvania were identified. Data were collected retrospectively using a Web-based interface in compliance with patient privacy standards. Inferential statistics were used to compare features of patients with and without macrophage activation syndrome.
RESULTS: We identified 136 patients; 88% of patients presented with arthritis (8% mono-, 45% oligo-, 47% polyarticular). The most common joints involved were the knee (68% of patients with arthritis), wrist (68%), and ankle (57%). The International League of Associations for Rheumatology criteria for systemic juvenile idiopathic arthritis (SJIA) identified only 30% of patients at presentation.
CONCLUSION: We successfully characterized the presenting features of a relatively rare disease, soJRA, through the use of a Web-based registry. Current classification criteria for SJIA may not be particularly sensitive for diagnosis at presentation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18085728

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  46 in total

Review 1.  Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management.

Authors:  Sathish Kumar
Journal:  Indian J Pediatr       Date:  2016-02-26       Impact factor: 1.967

2.  Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis.

Authors:  Hatice Ezgi Baris; Edwin Anderson; Betul Sozeri; Fatma Dedeoglu
Journal:  Clin Rheumatol       Date:  2018-09-20       Impact factor: 2.980

Review 3.  [Still's disease in children and adults].

Authors:  C M Hedrich; C Günther; M Aringer
Journal:  Z Rheumatol       Date:  2017-09       Impact factor: 1.372

Review 4.  Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review.

Authors:  Yvan Jamilloux; Alexandre Belot; Flora Magnotti; Sarah Benezech; Mathieu Gerfaud-Valentin; Emilie Bourdonnay; Thierry Walzer; Pascal Sève; Thomas Henry
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

5.  MEFV mutations in Egyptian children with systemic-onset juvenile idiopathic arthritis.

Authors:  Hala M Lotfy; Manal E Kandil; Marianne Samir Makboul Issac; Samia Salah; Nagwa Abdallah Ismail; Mohamed A Abdel Mawla
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

6.  Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis.

Authors:  Esi Morgan DeWitt; Yukiko Kimura; Timothy Beukelman; Peter A Nigrovic; Karen Onel; Sampath Prahalad; Rayfel Schneider; Matthew L Stoll; Sheila Angeles-Han; Diana Milojevic; Kenneth N Schikler; Richard K Vehe; Jennifer E Weiss; Pamela Weiss; Norman T Ilowite; Carol A Wallace
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-07       Impact factor: 4.794

Review 7.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan Dewitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-10       Impact factor: 4.794

8.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Rheum       Date:  2013-10

Review 9.  Glucocorticoids in the management of systemic juvenile idiopathic arthritis.

Authors:  Gaia Vannucci; Luca Cantarini; Teresa Giani; Edoardo Marrani; Davide Moretti; Ilaria Pagnini; Gabriele Simonini; Rolando Cimaz
Journal:  Paediatr Drugs       Date:  2013-10       Impact factor: 3.022

10.  Total knee arthroplasty in patients with juvenile idiopathic arthritis.

Authors:  Thomas J Heyse; Michael D Ries; Johan Bellemans; Stuart B Goodman; Richard D Scott; Timothy M Wright; Jospeh D Lipman; Ran Schwarzkopf; Mark P Figgie
Journal:  Clin Orthop Relat Res       Date:  2014-01       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.